mHealth Intervention for Older Adults
Promoting Lifestyle Changes With Mobile Health Technologies for Overweight or Obese Adults With Type 2 Diabetes - Feasibility and Acceptability Study
1 other identifier
interventional
9
1 country
1
Brief Summary
This is a pilot study to test the feasibility and acceptability of a self-regulation theory-based mHealth behavior intervention for overweight or obese older adults with T2DM.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 12, 2017
CompletedFirst Submitted
Initial submission to the registry
October 31, 2017
CompletedFirst Posted
Study publicly available on registry
January 12, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2018
CompletedOctober 22, 2018
October 1, 2018
1.1 years
October 31, 2017
October 19, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Acceptability
Actual Use of Technology will be defined as binary (use vs. nonuse) for each day based on data-stamp information. Then we will calculate percent days of use over time.
From baseline to the end of study (up to 3 months)
Secondary Outcomes (3)
Percent weight change
From baseline to the end of study (up to 3 months)
Steps
From baseline to the end of study (up to 3 months)
Calorie intake
Mean steps over 3 months
Study Arms (1)
mHealth Intervention for Older Adults
EXPERIMENTALPilot study to test the feasibility and acceptability of a self-regulation theory-based mHealth behavior intervention for overweight or obese older adults with T2DM. This is a one Group Pretest-Posttest Designed study. Ten participants will be recruited from Joslin Diabetes Center, Boston, MA. They will receive a 2-month, self-regulation theory-based weight loss intervention (five 60-minute, biweekly group sessions) and will be provided with a technology toolkit for self-monitoring including an (1) iPhone Plus, (2) the Lose It! app for self-monitoring of dietary intake, (3) Fitbit for self-monitoring of physical activity, (4) Bluetooth-enabled scale for daily weight, and (5) Bluetooth-enabled blood glucose monitor for testing blood glucose levels.
Interventions
Participants will receive a self-regulation theory-based mHealth behavior intervention (5 biweekly group sessions, 60 minutes /session). An experienced Certified Diabetes Educator from the Joslin Diabetes Center and PI (Dr. Zheng) who has been trained using self-regulation for weight loss will co-facilitate group sessions. The intervention combines diet modification and increased physical activity with a weekly weight loss goal as well as focuses on improving participants' three typical self-regulation strategies - self-monitoring, self-evaluation and self-reinforcement. Intervention duration will last 2 months with subsequent 1-month follow.
Eligibility Criteria
You may qualify if:
- \>=65 years of age;
- BMI between 27-40kg/m2
- Availability of wireless Internet service at home;
- Stable body weight during the previous year (i.e., ±10 pounds) ;
- Not being enrolled in another weight loss program in the past six months;
- Diagnosed with type 2 diabetes for at least 2 years;
- Prescribed insulin or oral medications for at least 1 year;
- No changes in medications for at least 6 months before enrolling in the study;
- Use the LoseIt! app on their computer or smartphone for the 5-day practice period;
- Able to read, write and speak English.
You may not qualify if:
- Planning frequent travel, vacations or relocation in next 3 months;
- Current use of weight loss medication;
- Have a history of bariatric surgery;
- Have participated in diabetes education in the previous 12 months;
- Are unable to walk 2 blocks, or had an amputation of a lower limb, severe arthritis or other medical condition that prevents walking for exercise;
- Have severe complications of diabetes, including renal disease (albumin/creatinine \>300 μg /mg), severe peripheral diabetic neuropathy, severe peripheral vascular disease, symptomatic autonomic neuropathy, history of myocardial infarction, congestive heart failure, or other severe cardiac disease or severe hypertension (systolic blood pressure greater than 160/90 mmHg);
- Have a diagnosis of a serious mental illness, e.g. schizophrenia, bipolar disorder, substance abuse, and/or eating disorders;
- Have severe visual, hearing or cognitive impairments (e.g., dementia, intellectual disability);
- Unable or unwilling to use the mHealth technology equipment (toolkit) for data collection;
- Do not speak, read and write English.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Boston Collegelead
- Joslin Diabetes Centercollaborator
Study Sites (1)
Joslin Diabetes Center
Boston, Massachusetts, 02215, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yaguang Zheng, PhD
Boston College Connell School of Nursing
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
October 31, 2017
First Posted
January 12, 2018
Study Start
April 12, 2017
Primary Completion
May 30, 2018
Study Completion
May 30, 2018
Last Updated
October 22, 2018
Record last verified: 2018-10